Exchange: NASDAQ·Updated 12:27 PM EDT
News
all
press releases
Zacks.com featured highlights include CareDx, Healthcare Services, Forum Energy Tech, Amneal Pharma and Caterpillar
CareDx, Healthcare Services Group, Forum Energy Technologies, Amneal Pharmaceuticals and Caterpillar emerge as high-efficiency stocks poised for stronger returns.
Zacks
More News
5 Top-Ranked High-Efficiency Stocks Poised for Stronger Returns
Five stocks, including CareDx and Caterpillar, cleared an efficiency screen based on key ratios exceeding industry averages.
Zacks
Baron Discovery Fund Gains from Strategic Accumulation of CareDx (CDNA)
Baron Discovery Fund Gains from Strategic Accumulation of CareDx (CDNA...
Yahoo! Finance: News
SNOW, CDNA Stocks Hit Fresh 52-Week Highs – What’s Driving Investor Optimism Today?
Snowflake and CareDx received favorable reviews from Wall Street firms, following better-than-expected second-quarter prints and bullish momentum across AI products, respectively.
Stocktwits
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx, Inc. (Nasdaq: CDNA) a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced that, on July 30, 2026, CareDx granted to James McNally, the Companys newly appointed Executive Advisor, certain stock awards as an inducement material...
Business Wire
Why CareDx Stock Jumped Today
Key PointsCareDx is helping to improve outcomes for transplant patients...
Nasdaq News: Markets
CareDx (CDNA) Beats Q2 Earnings and Revenue Estimates
CareDx (CDNA) delivered earnings and revenue surprises of +68.18% and +15.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
CareDx Announces Second Quarter 2026 Financial Results
CareDx, Inc. (Nasdaq: CDNA) a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Revenue of $132 million, an increase of 52...
Business Wire
Ardent Health, Inc. (ARDT) Expected to Beat Earnings Estimates: Should You Buy?
Ardent Health, Inc. (ARDT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
CareDx (CDNA) Earnings Expected to Grow: Should You Buy?
CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks

Advertisement|Remove ads.